Novavax news from FierceBiotech

A new bird flu vaccine developed by Novavax from insect cell cultures proved effective in spurring an immune response in a human trial. The Rockville, MD-based developer has been pursuing a Read more...

> FDA staffers say that Solvay's experimental therapy for atrial fibrillation is approvable--with conditions. Report > Shares of Read more...

Press Release: Novavax Licenses Wyeth's Virus-Like Particle Technology

Read more...

Wyeth could gain up to $5 million through next year in a licensing deal with Novavax covering its virus-like particle technology for use in vaccine development. The technology creates viruses that mimic the disease-causing virus but lacks genetic material needed to make it a threat. Release

Akesis Pharmaceuticals has appointed Jay Lichter, Ph.D., a veteran biotechnology and pharmaceutical business executive, as its new president and CEO. Dr. Lichter replaces Edward B. Wilson, who has resigned from the company to pursue other opportunities.

Todd Pope has left his post as CEO of Liquidia …

Read more...

Momenta Pharmaceuticals has tapped Craig Wheeler, the former president of Chiron BioPharmaceuticals, to be its next CEO. Alan Crane, who's stepping down from the post, will stay on the board.

Fresh from raising $60 million in new venture funds, Prestwick Pharmaceuticals has named George F. Horner III …

Read more...

Recent headlines about a cluster of avian flu deaths in Indonesia could be felt among biotech companies working on the virus. A host of stocks, from Novavax to BioCryst to Generex and more, saw their stocks go up as investors reacted to the headlines by buying up shares. Analysts say that every time a new headline hits newspapers and the Internet, we're likely to experience gyrations on the stock market.

- here's the …

Read more...

AstraZeneca buys CAT for $1.3B

Read more...

> Esprit Pharma has inked a deal to collaborate with Novavax on the development of a mid-stage testosterone therapy for women with sexual dysfunction. Report

> Novartis unveiled new data that demonstrates is blockbuster blood pressure drug Diovan also influences a key marker in inflammation linked to higher risk of heart attacks and strokes. …

Read more...

Germany's Pieris Proteolab has appointed Evert Kuppers as CEO. Kuppers joins Pieris from IDEA, where he was vice president and head of business development.

NPS Pharmaceuticals has appointed its COO and president, Tony Coles, as its CRO. Coles succeeds Hunter Jackson, who stepped down as the company's …

Read more...